Comparison of the effect of Myrtus herbal mouthwash versus chlorhexidine mouthwash on the prevention of Ventilator Associated Pneumonia

Not Applicable

Conditions: Ventilator Associated Pneumonia.
Diseases of the respiratory system:pneumonia
J00-J99

Registration Number: IRCT20200705048006N1

Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Female

Target Recruitment: 70

Inclusion Criteria

The main caregiver of the patient should be consciously satisfied to participate in the research (due to the disorder in the patient's level of consciousness)
The patient's age should be between 70-18 years
Immunosuppressive diseases and underlying lung disease are not recognized by the treating physician
Do not have a specific lesion in or around the mouth
Has no history of allergy to herbal ingredients (according to the history obtained from the patient's primary caregiver)
Under mechanical ventilation through the endotracheal tube
At the time of hospitalization in the ICU and intubation, there is no evidence of pneumonia in chest radiography at the discretion of the treating physician
Must be mechanically ventilated for at least the next 48 hours (according to the definition of Ventilator Associated Pneumonia)

Exclusion Criteria

Withdrawal of the patient's primary caregiver from continuing the study
Transfer or death of the patient, removal of the endotracheal tube before 48 hours
Allergic reaction to mouthwash
Observation of obvious aspiration (observation of gastric material during endotracheal tube suction, change of position, cough, etc.)
Do not have an upper airway infection (based on your doctor's diagnosis)

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevention of Ventilator Associated Pneumonia. Timepoint: Before the intervention and the fifth day after the intervention. Method of measurement: Clinical Pulmonary Infection Scale.

Secondary Outcome Measures